INAVOLISIB

UNII:	L4C1UY2NYH
Formula:	C₁₈H₁₉F₂N₅O₄
Preferred Substance Name:	INAVOLISIB
InChIKey:	SGEUNORSOZVTOL-CABZTGNLSA-N

2060571-02-8
(2S)-2-((2-((4S)-4-(DIFLUOROMETHYL)-2-OXO-1,3-OXAZOLIDIN-3-YL)-5,6-DIHYDROIMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)AMINO)PROPANAMIDE
(2S)-2-((2-((4S)-4-(DIFLUOROMETHYL)-2-OXO-3-OXAZOLIDINYL)-5,6-DIHYDROIMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)AMINO)PROPANAMIDE
GDC0077
GDC-0077
INAVOLISIB [INN]
INAVOLISIB [USAN]
INAVOLISIB [WHO-DD]
ITOVEBI
PROPANAMIDE, 2-((2-((4S)-4-(DIFLUOROMETHYL)-2-OXO-3-OXAZOLIDINYL)-5,6-DIHYDROIMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)AMINO)-, (2S)-
RG6114
RG-6114
RO7113755
RO-7113755

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

INAVOLISIB

Synonyms and Mappings

Resources